Cargando…
The utility of syndecan-1 circulating levels as a biomarker in patients with previous or active COVID-19: a systematic review and meta-analysis
BACKGROUND: With the emergence of coronavirus disease of 2019 (COVID-19), several blood biomarkers have been identified, including the endothelial biomarker syndecan-1, a surface proteoglycan. In the current systematic review and meta-analysis, we aimed to assess the diagnostic and prognostic role o...
Autores principales: | Ghondaghsaz, Elina, Khalaji, Amirmohammad, Norouzi, Mitra, Fraser, Douglas D., Alilou, Sanam, Behnoush, Amir Hossein |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10401738/ https://www.ncbi.nlm.nih.gov/pubmed/37542221 http://dx.doi.org/10.1186/s12879-023-08473-9 |
Ejemplares similares
-
Insights into the Role of Galectin-3 as a Diagnostic and Prognostic Biomarker of Atrial Fibrillation
por: Mohtasham Kia, Yasmin, et al.
Publicado: (2023) -
Adjunctive therapy with lipid-lowering agents in COVID-19: a systematic review and meta-analysis of randomized controlled trials
por: Khalaji, Amirmohammad, et al.
Publicado: (2023) -
The interplay between vitamin C and thyroid
por: Farasati Far, Bahareh, et al.
Publicado: (2023) -
High circulating endocan in chronic kidney disease? A systematic review and meta-analysis
por: Khalaji, Amirmohammad, et al.
Publicado: (2023) -
Association between vitamin D deficiency and vasovagal syncope: A systematic review and meta‐analysis
por: Khalaji, Amirmohammad, et al.
Publicado: (2023)